EN DE
Watch Ganesh Benzoplast Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Ganesh Benzoplast Limited (GANESHBE) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of Ganesh Benzoplast Limited stock ₹87.02, price ₹92.86, that is 6.3% below the price, quality 49 out of 100. Rating: fairly valued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials IN · ISIN INE388A01029

GB Ganesh Benzoplast Limited logo Thin data Nov 15, 2026

Ganesh Benzoplast Limited

GANESHBE · NSE

Rising price, but the stock is already about fairly priced and weak company: meets 1 of 3 rules.

Get notified free when this changes
Rising price (uptrend) 
Solidly profitable · 16.8% net margin (TTM) 
Low debt 
Generates free cash flow 
Ranks above peers (10/13) 
Revenue last quarter +23% vs. a year ago. 
Fair value ₹87.02 · Fairly valued 
Quality 49/100 
Expensive Growth (revenue YoY +9.9 %/yr in INR) 
Moderate moat 63/100 · thin data
Thin data 
⟳ Cyclical
Watch Ganesh Benzoplast Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹211.45 ₹69.52 Fair Value ₹87.02 Sep 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.

How to read this chart

60‑month range ₹69.52 – ₹211.45 · fair‑value band ₹51.68 – ₹143.80 · the ₹92.86 price screens above the ₹87.02 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.

Follow Ganesh Benzoplast in your weekly email

Every Wednesday you see whether Ganesh Benzoplast is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Ganesh Benzoplast Limited engages in the manufactures and sells specialty chemicals, food preservatives, and industrial lubricants in India and internationally. It operates through two segments, Liquid Storage Tanks and Chemical.

Show moreShow less

The company provides liquid storage tanks; engineering procurement and construction services; rail logistic services; storage and handling solutions; and transportation facilities.

It offers lubricant additives that includes engine, driveline, and industrial lubricant additives; detergent/dispersant, antiwear/anti-oxidant, and other components; sodium, calcium, barium, and magnesium petroleum sulphonate chemicals; and other lube specialty chemicals, such as brake fluid.

In addition, the company offers chemicals comprising sodium benzoate, benzoic acid, methyl benzoate, and benzoate plasticisers. Further, it provides bunkering, blending, and drum filling services. The company serves food and beverage, paints, automobile, pharmaceutical, and lubricants industries.

Ganesh Benzoplast Limited was incorporated in 1986 and is headquartered in Mumbai, India.

Stock analysis

Ganesh Benzoplast Limited (GANESHBE) currently trades at ₹92.86, while our model-based Fair Value estimate is ₹87.02, so the stock looks roughly fairly valued today (gap 6.7%).

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ₹178.19 per share, and 11 of the 24 models we run sit above the ₹92.86 price.

Bear case: the Growth DCF group reads lowest at ₹59.29, and 13 of the 24 models stay below the price. Data coverage for this calculation is low.

Scenario range: ₹51.68 (bear) to ₹143.80 (bull), the price of ₹92.86 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 49/100 (below-average quality), in the Basic Materials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Ganesh Benzoplast Limited reported revenue of ₹4.1B in FY2026 versus ₹3.6B in FY2022, a compound +3.6%/yr. Reported net income was ₹733M in FY2026, compounding +22.4%/yr from FY2022.

Key figures

Market cap ₹6.7B (≈ $70.9M) Micro · P/E ratio 9.2 · P/S ratio 1.54 · EPS (TTM) ₹10.10 · Net margin 16.8% · Return on equity 12.6% · Return on assets (EBIT) 11.3% (5-year average) · Operating margin 17.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 63 out of 100 (low confidence).

What moves the price

The share trades about 33% below its 52-week high and 34% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −48% fair-value upside, at −6%, GANESHBE screens cheaper than that median.

Fair Value models

Bear ₹51.68 Fair Value ₹87.02 Bull ₹143.80
Price ₹92.86 · Downside -6.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹6.36 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF ₹26.29 ₹34.87 ₹46.86 81
Growth DCF ₹25.94 ₹33.18 ₹42.50 80
Owner Earnings ₹23.47 ₹30.45 ₹40.22 78
All 24 models by family
DCF Models
FCF DCF ₹26.29 ₹34.87 ₹46.86 81
Owner Earnings ₹23.47 ₹30.45 ₹40.22 78
5Y Revenue Exit ₹50.43 ₹87.02 ₹138.04 71
5Y EBITDA Exit ₹67.36 ₹122.20 ₹192.62 73
5Y P/E Exit ₹83.89 ₹156.54 ₹241.49 69
10Y Revenue Exit ₹37.60 ₹64.17 ₹106.73 65
10Y EBITDA Exit ₹48.05 ₹85.04 ₹143.80 66
10Y P/E Exit ₹56.93 ₹105.41 ₹177.00 62
Earnings-Based
Graham-Dodd ₹69.27 ₹333.48 ₹459.14 64
Lynch FV ₹89.07 ₹127.24 ₹165.41 61
PEG = 1.0 ₹89.07 ₹127.24 ₹165.41 57
EPV ₹51.68 ₹56.08 ₹59.59 74
Multiples
P/E Multiple ₹129.88 ₹173.18 ₹216.47 63
P/S Multiple ₹64.29 ₹85.72 ₹107.16 58
P/B Multiple ₹144.93 ₹193.24 ₹241.55 55
EV/EBIT ₹102.02 ₹135.86 ₹169.69 66
EV/EBITDA ₹98.00 ₹130.49 ₹162.99 67
EV/Revenue ₹60.52 ₹86.24 ₹111.95 53
Asset-Based
NCAV (Graham) ₹0.4700 ₹0.7100 ₹0.8900 54
Growth DCF
Growth DCF ₹25.94 ₹33.18 ₹42.50 80
Rev-Margin DCF ₹50.43 ₹85.40 ₹130.93 71
Economic Profit
Residual Income ₹68.08 ₹73.76 ₹85.19 71
ROIC Compounder ₹51.68 ₹56.08 ₹59.59 72
Growth Earnings
Growth-Adj P/E ₹124.73 ₹178.19 ₹231.64 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 49/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 53
How much profit the company makes from its sales and capital
Quality Growth 46
Are margins and returns getting better?
Cashflow 31
Do the profits arrive as real cash?
Financial strength 82
Debt, balance sheet and risk of trouble
Investment 14
Does it invest with discipline instead of growing at any price?
Low Volatility 61
How calm the share price moves, does not count
Price momentum 40
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 42
Distance to the 52-week high, does not count
New shares 63
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+14.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+14.2%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.14.2% vs 15.3%, steady
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.25% → 17%
Pace: the 5-year rate starts in 2021 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+44.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +38.5% a year for the price.

Watch GANESHBE, get fair value alerts →

Compare Ganesh Benzoplast Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 755 stocks

Beats the industry median on 9/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 49 · Below median
Fair Value upside −6.3% · Above median
Profitability
Return on equity (12 months) 12.6% · Top 25%
Return on assets 8.6% · Top 25%
Net margin (12 months) 16.8% · Top 25%
Operating margin (12 months) 17.7% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 22.9% · Above median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (12 months) 9.2× · Cheapest 25%
P/B 1.09× · Cheaper than median
P/S (12 months) 1.54× · Pricier than median
Price / free cash flow (fiscal year) 72.7× · Priciest 25%
EV/EBITDA 6.4× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)25 · sector 4
FUTURE (revenue growth)100 · sector 67
PAST (return on equity)50 · sector 25
HEALTH (low debt)100 · sector 95
DIVIDEND (yield)0 · sector 30

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wanhua Chemical Group 600309 ¥68.09 ¥68.03 +0% vs GANESHBE
Linde plc LIN $526.06 $446.62 −15% vs GANESHBE
PPG Industries, Inc PPG $122.56 $77.68 −37% vs GANESHBE
DSM-Firmenich AG DSFIR CHF 97.75 CHF 58.34 −40% vs GANESHBE
Sika AG SIKA CHF 191.95 CHF 98.89 −48% vs GANESHBE
The Sherwin-Williams Company SHW $349.89 $152.59 −56% vs GANESHBE
Givaudan SA GIVN CHF 4,090 CHF 1,629 −60% vs GANESHBE
EMS-CHEMIE HOLDING AG EMSN CHF 846.50 CHF 284.63 −66% vs GANESHBE
Ecolab Inc ECL $309.27 $97.18 −69% vs GANESHBE
Air Products and Chemicals, Inc APD $316.53 $75.33 −76% vs GANESHBE

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Ganesh Benzoplast Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Ganesh Benzoplast Limited Fair Value". https://www.fairvalue-calculator.com/stock/GANESHBE

Frequently asked questions

Is Ganesh Benzoplast Limited (GANESHBE) overvalued or undervalued?
As of Nov 15, 2026, our model estimates a fair value of ₹87.02 versus a price of ₹92.86, about 6% lower (fairly valued).
What is the fair value of GANESHBE?
Our model-based fair value for Ganesh Benzoplast Limited is ₹87.02 (as of Nov 15, 2026), built from audited fundamentals. The current price: ₹92.86.
What is the quality score of GANESHBE?
Ganesh Benzoplast Limited has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Ganesh Benzoplast Limited (GANESHBE)?
Our model-based price target is the fair value of ₹87.02 (as of Nov 15, 2026) from 24 valuation models. Cautious scenario ₹51.68, optimistic scenario ₹143.80. It is a calculation from audited fundamentals, not an analyst target.
What is the Ganesh Benzoplast Limited stock forecast for 2026?
Our models put fair value at ₹87.02, about 6% lower versus a price of ₹92.86 (fairly valued). Cautious scenario ₹51.68, optimistic scenario ₹143.80. The calculation is refreshed regularly with new filings.
What is the revenue of Ganesh Benzoplast Limited (GANESHBE)?
Ganesh Benzoplast Limited reported trailing-twelve-month revenue of about ₹4.3B (latest available figure, as of Nov 15, 2026).
What growth is priced into Ganesh Benzoplast Limited (GANESHBE)?
For today's price to be fair in a discounted-cash-flow model, Ganesh Benzoplast Limited would have to grow free cash flow by 44.2 % per year for five years (discount rate 13.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 8.8 % per year. As of Nov 15, 2026.
What discount rate (WACC) does the fair value of GANESHBE use?
Our models discount Ganesh Benzoplast Limited at 13.9 %: a base by market capitalisation (micro), damped by beta 0.06, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Ganesh Benzoplast Limited that is +44.2 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.9 %) and the same formula as our fair value.
How much growth has Ganesh Benzoplast Limited (GANESHBE) delivered so far?
Over the past 5 years revenue at Ganesh Benzoplast Limited grew 8.8 % a year. The price currently implies free-cash-flow growth of +44.2 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Ganesh Benzoplast Limited (GANESHBE) growing?
The median revenue growth in the sector is +8.8 % a year. That is the yardstick for the growth priced into Ganesh Benzoplast Limited (+44.2 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Ganesh Benzoplast Limited (GANESHBE)?
The free-cash-flow yield on the price is 1.37 %: that much free cash flow Ganesh Benzoplast Limited produces per unit of market value. When it exceeds the discount rate of our models (13.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Ganesh Benzoplast Limited (GANESHBE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Ganesh Benzoplast Limited it is ₹87.02 per share (as of Nov 15, 2026), against a price of ₹92.86. It is the blended result of 24 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Ganesh Benzoplast Limited stock overvalued or undervalued in 2026?
As of Nov 15, 2026, GANESHBE trades above its calculated fair value: price ₹92.86, fair value ₹87.02, a gap of about −6% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GANESHBE?
No. The price is what the market pays today (₹92.86); the fair value is what the company's own numbers justify (₹87.02). For Ganesh Benzoplast Limited the two are ₹5.84 per share apart. That gap is exactly why we show both numbers side by side.
How much is Ganesh Benzoplast Limited worth?
The market values Ganesh Benzoplast Limited at about ₹6.7B (market capitalisation, as of Nov 15, 2026). Per share that is ₹92.86; our models calculate a fair value of ₹87.02 per share.
What do the bullish and bearish scenarios say about GANESHBE?
Our models span a range for Ganesh Benzoplast Limited: cautious scenario ₹51.68, base ₹87.02, optimistic ₹143.80 per share (as of Nov 15, 2026, price ₹92.86). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of GANESHBE?
Ganesh Benzoplast Limited trades at a price-to-earnings ratio of 9.2 (as of Nov 15, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹87.02 is built from several models across several years. Median P/E at fiscal year-end, 5 fiscal years (2022 to 2026), reported earnings: 19.5. Other multiples: P/B 1.1, P/S 1.5, EV/EBITDA 6.4.
How solid is the balance sheet of Ganesh Benzoplast Limited (GANESHBE)?
Balance-sheet figures for Ganesh Benzoplast Limited (as of Nov 15, 2026): return on equity 12.6%. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is GANESHBE from its 52-week high?
Ganesh Benzoplast Limited trades at ₹92.86, about 33% below its 52-week high of ₹137.83 and 34% above the low of ₹69.52 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of ₹87.02 is for.
Which stocks are comparable to Ganesh Benzoplast Limited?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Ganesh Benzoplast Limited stock attractive at the current price?
The data as of Nov 15, 2026: price ₹92.86, calculated fair value ₹87.02 (−6%), Quality Score 49/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GANESHBE calculated?
We run Ganesh Benzoplast Limited through 24 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹87.02 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. Ganesh Benzoplast Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Ganesh Benzoplast Limited (GANESHBE)?
The closing price on Nov 13, 2026 was ₹92.86. Our model-based fair value is ₹87.02, about 6% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Ganesh Benzoplast Limited right now?
The model range is unusually wide (₹51.68 to ₹143.80). The outcome hinges heavily on assumptions, so read the point estimate with caution. The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Where does the earnings growth of Ganesh Benzoplast Limited (GANESHBE) come from?
Earnings per share at Ganesh Benzoplast Limited grew 8.5 % a year from 2015 to 2026. Broken into its drivers: revenue per share +11.1 %, EBIT margin +0.9 %, tax rate −3.2 %, residual (interest, one-offs) +0.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Ganesh Benzoplast Limited

How large is the market capitalisation of Ganesh Benzoplast Limited (GANESHBE)?
The market capitalisation of Ganesh Benzoplast Limited is ₹6.7B (≈ $70.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Ganesh Benzoplast Limited (GANESHBE)?
The price-to-sales ratio of Ganesh Benzoplast Limited is 1.54 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Ganesh Benzoplast Limited (GANESHBE)?
Earnings per share at Ganesh Benzoplast Limited are ₹10.10 (price ÷ EPS = P/E 9.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Ganesh Benzoplast Limited (GANESHBE)?
The net margin of Ganesh Benzoplast Limited is 16.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Ganesh Benzoplast Limited (GANESHBE)?
The return on equity (ROE) of Ganesh Benzoplast Limited is 12.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Ganesh Benzoplast Limited (GANESHBE)?
On an EBIT basis the return on assets of Ganesh Benzoplast Limited is 11.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Ganesh Benzoplast Limited (GANESHBE)?
The operating margin of Ganesh Benzoplast Limited is 17.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Ganesh Benzoplast Limited (GANESHBE)?
Revenue at Ganesh Benzoplast Limited is growing 22.9% versus a year earlier (3y avg −0.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Ganesh Benzoplast Limited (GANESHBE)?
Earnings per share at Ganesh Benzoplast Limited are down 3.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Ganesh Benzoplast Limited (GANESHBE) hold?
Ganesh Benzoplast Limited holds more cash than debt, ₹36.9M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Ganesh Benzoplast Limited in the live analysis

One click puts Ganesh Benzoplast Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.